131 related articles for article (PubMed ID: 33228856)
1. Factors Affecting Quality of Life for People Living with Albinism in Botswana.
Anshelevich EE; Mosojane KI; Kenosi L; Nkomazana O; Williams VL
Dermatol Clin; 2021 Jan; 39(1):129-145. PubMed ID: 33228856
[TBL] [Abstract][Full Text] [Related]
2. Sociodemographic features of a cohort of people living with albinism in Botswana.
Chu B; Maranga A; Mosojane KI; Allen-Taylor L; Ralethaka M; Ngubula JC; Shifa JZ; Jereni BH; Nkomazana O; Williams VL
JAAD Int; 2021 Mar; 2():153-163. PubMed ID: 34409362
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the acceptance and efficacy of a bespoke sun protection package for persons with oculocutaneous albinism living in Malawi.
Gilaberte Y; Mzumara TE; Manjolo SP; Kaseko N; Bagazgoitia L; Fuller LC; Soto M
Int J Dermatol; 2022 Mar; 61(3):352-360. PubMed ID: 34490895
[TBL] [Abstract][Full Text] [Related]
4. Children with albinism in African regions: their rights to 'being' and 'doing'.
Franklin A; Lund P; Bradbury-Jones C; Taylor J
BMC Int Health Hum Rights; 2018 Jan; 18(1):2. PubMed ID: 29329540
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in patients with oculocutaneous albinism.
Maia M; Volpini BM; dos Santos GA; Rujula MJ
An Bras Dermatol; 2015; 90(4):513-7. PubMed ID: 26375220
[TBL] [Abstract][Full Text] [Related]
6. [A case for the inclusion of oculocutaneous albinism as a skin-related Neglected Tropical Disease].
Aquaron R; Lund P; Baker C
Med Trop Sante Int; 2023 Dec; 3(4):. PubMed ID: 38390024
[TBL] [Abstract][Full Text] [Related]
7. Attitudes and beliefs of an albino population toward sun avoidance: advice and services provided by an outreach albino clinic in Tanzania.
McBride SR; Leppard BJ
Arch Dermatol; 2002 May; 138(5):629-32. PubMed ID: 12020224
[TBL] [Abstract][Full Text] [Related]
8. Squamous-cell carcinoma in situ in a patient with oculocutaneous albinism.
Berger E; Hunt R; Tzu J; Patel R; Sanchez M
Dermatol Online J; 2011 Oct; 17(10):22. PubMed ID: 22031648
[TBL] [Abstract][Full Text] [Related]
9. Patterns of skin cancer and treatment outcomes for patients with albinism at Kisangani Clinic, Democratic Republic of Congo.
Inena G; Chu B; Falay D; Limengo B; Matondo I; Bokanga A; Kovarik C; Williams VL
Int J Dermatol; 2020 Sep; 59(9):1125-1131. PubMed ID: 32530079
[TBL] [Abstract][Full Text] [Related]
10. Albinism in Africa: stigma, slaughter and awareness campaigns.
Cruz-Inigo AE; Ladizinski B; Sethi A
Dermatol Clin; 2011 Jan; 29(1):79-87. PubMed ID: 21095532
[TBL] [Abstract][Full Text] [Related]
11. Determining the competences of community based workers for disability-inclusive development in rural areas of South Africa, Botswana and Malawi.
Lorenzo T; van Pletzen E; Booyens M
Rural Remote Health; 2015; 15(2):2919. PubMed ID: 26048267
[TBL] [Abstract][Full Text] [Related]
12. The influence of perceived medical risks and psychosocial concerns on photoprotection behaviours among adults with xeroderma pigmentosum: a qualitative interview study in the UK.
Morgan M; Anderson R; Walburn J; Weinman J; Sarkany R
BMJ Open; 2019 Feb; 9(2):e024445. PubMed ID: 30782905
[TBL] [Abstract][Full Text] [Related]
13. A health intervention programme for children with albinism at a special school in South Africa.
Lund PM; Gaigher R
Health Educ Res; 2002 Jun; 17(3):365-72. PubMed ID: 12120851
[TBL] [Abstract][Full Text] [Related]
14. A sociological study of children with albinism at a special school in the Limpopo province.
Gaigher RJ; Lund PM; Makuya E
Curationis; 2002 Nov; 25(4):4-11. PubMed ID: 14509105
[TBL] [Abstract][Full Text] [Related]
15. 'The moment I leave my home - there will be massive challenges': experiences of living with a spinal cord injury in Botswana.
Löfvenmark I; Norrbrink C; Nilsson Wikmar L; Löfgren M
Disabil Rehabil; 2016 Jul; 38(15):1483-92. PubMed ID: 26694314
[TBL] [Abstract][Full Text] [Related]
16. "
Schenk KD; Tun W; Sheehy M; Okal J; Kuffour E; Moono G; Mutale F; Kyeremaa R; Ngirabakunzi E; Amanyeiwe U; Leclerc-Madlala S
Disabil Rehabil; 2020 Feb; 42(3):335-348. PubMed ID: 30282493
[No Abstract] [Full Text] [Related]
17. Access to assistive technology in two Southern African countries.
Matter RA; Eide AH
BMC Health Serv Res; 2018 Oct; 18(1):792. PubMed ID: 30340484
[TBL] [Abstract][Full Text] [Related]
18. Oculocutaneous albinism in southern Africa: Historical background, genetic, clinical and psychosocial issues.
Kromberg JGR; Kerr R
Afr J Disabil; 2022; 11():877. PubMed ID: 36353393
[TBL] [Abstract][Full Text] [Related]
19. Albinism.
Haefemeyer JW; Knuth JL
J Ophthalmic Nurs Technol; 1991; 10(2):55-62. PubMed ID: 2020024
[TBL] [Abstract][Full Text] [Related]
20. Albinism in Africa: a medical and social emergency.
Brilliant MH
Int Health; 2015 Jul; 7(4):223-5. PubMed ID: 26063702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
